AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E1238-E1239, 2007; doi:10.1152/ajpendo.00060.2007
0193-1849/07 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stellingwerff, T.
Right arrow Articles by Spriet, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stellingwerff, T.
Right arrow Articles by Spriet, L. L.

LETTERS TO THE EDITOR

Reply to letter "Pyruvate metabolism in working human skeletal muscle" by Henderson et al.

Trent Stellingwerff, George J. F. Heigenhauser, and Lawrence L. Spriet

Department of Human Health and Nutritional Sciences
University of Guelph
Guelph, ON, Canada N1G 2W1
Department of Medicine
McMaster University
Hamilton, ON, Canada L8N 3Z5
heigeng{at}mcmaster.ca

The following is the abstract of the article discussed in the subsequent letter:

The aim of this study was to determine whether the decreased muscle and blood lactate during exercise with hyperoxia (60% inspired O2) vs. room air is due to decreased muscle glycogenolysis, leading to decreased pyruvate and lactate production and efflux. We measured pyruvate oxidation via PDH, muscle pyruvate and lactate accumulation, and lactate and pyruvate efflux to estimate total pyruvate and lactate production during exercise. We hypothesized that 60% O2 would decrease muscle glycogenolysis, resulting in decreased pyruvate and lactate contents, leading to decreased muscle pyruvate and lactate release with no change in PDH activity. Seven active male subjects cycled for 40 min at 70% VO2 peak on two occasions when breathing 21 or 60% O2. Arterial and femoral venous blood samples and blood flow measurements were obtained throughout exercise, and muscle biopsies were taken at rest and after 10, 20, and 40 min of exercise. Hyperoxia had no effect on leg O2 delivery, O2 uptake, or RQ during exercise. Muscle glycogenolysis was reduced by 16% with hyperoxia (267 ± 19 vs. 317 ± 21 mmol/kg dry wt), translating into a significant, 15% reduction in total pyruvate production over the 40-min exercise period. Decreased pyruvate production during hyperoxia had no effect on PDH activity (pyruvate oxidation) but significantly decreased lactate accumulation (60%: 22.6 ± 6.4 vs. 21%: 31.3 ± 8.7 mmol/kg dry wt), lactate efflux, and total lactate production over 40 min of cycling. Decreased glycogenolysis in hyperoxia was related to an ~44% lower epinephrine concentration and an attenuated accumulation of potent phosphorylase activators ADPf and AMPf during exercise. Greater phosphorylation potential during hyperoxia was related to a significantly diminished rate of PCr utilization. The tighter metabolic match between pyruvate production and oxidation resulted in a decrease in total lactate production and efflux over 40 min of exercise during hyperoxia.

To the Editor: We would like to respond to the letter to the editor written by Henderson et al. in this Journal's January issue (6). Our laboratory would have appreciated the chance to have immediately rebutted the original letter to the editor, but we were not made aware of it until its final publication. The aim of our study was to examine the effects of hyperoxia on decreasing muscle and blood lactate concentrations, and thus required lactate release measurements (10). In previous studies from our laboratory, we measured lactate release to account for the removal of three carbon units derived from glycolysis during exercise. This was based on existing literature, which showed that the majority of 3-carbon-unit release from exercising muscle was lactate, with concurrent pyruvate release being minor in comparison (1, 2, 7, 9). However, after reading the 2004 Henderson et al. paper (5) with much interest, which reported that working muscles released the same amount of lactate and pyruvate, we decided that both metabolites must be measured in order to get an accurate estimate of total carbohydrate-derived 3-carbon-unit release across the exercising muscle. However, contrary to Henderson et al. (5), we found nearly a fivefold greater net lactate release during exercise compared with pyruvate release. Unlike the recent letter to the editor from Henderson et al., which surprisingly seems to focus only on pyruvate exchange across working muscles, we would like to further discuss the release of both pyruvate and lactate. This discussion is in line with the original Henderson paper, which states seven times "that working muscle releases similar amounts of lactate and pyruvate."

In agreement with the Brooks laboratory, there is a paucity of data that examine the net exchange of pyruvate across working skeletal muscle in humans. Thus, very few data sets examine both pyruvate and lactate exchange simultaneously during exercise. To our knowledge, there are only four previous studies that have examined both pyruvate and lactate release in vivo in humans, and all four of those studies have reported greater net lactate release than pyruvate release during at least the first 90 min of exercise (1, 2, 7, 9). In fact, Henderson et al. even alluded to this in their original paper when they stated, "Others have shown significant muscle pyruvate release during exercise in dogs and humans (1, 9), although at most time points the net lactate release was greater than net pyruvate release." Therefore, we stand by our original conclusions that the Henderson paper seems to be "at odds with the majority of published results" when pertaining to their conclusion that working muscle releases the same amounts of lactate and pyruvate.

When one methodically studies the paper from Henderson et al. (5), and their related paper that was published five years earlier (3), it becomes apparent that there are several ambiguous statements regarding the time course of their pyruvate and lactate release data, and there appear to be several methodological errors. First, since there are fluid shifts occurring between muscle and the vascular space during exercise, plasma protein, hemoglobin, and hematocrit are often used to provide a measure of relative changes in intravascular volume when applying the Fick equation. Unfortunately, there is no mention of whether this was done in the Henderson study (5). However, their companion paper (3) does mention that they used a hematocrit correction instead of using a plasma protein-based correction for changes in venous plasma volume. In fact, a hematocrit correction can cause such a disparity in the data that some refuse to accept that the hematocrit correction has any validity whatsoever as a measure of change in plasma volume (4). Second, when their two papers are closely examined (3, 5), it becomes apparent that pyruvate was measured in whole blood whereas lactate was measured in the plasma. To our knowledge, there are no data examining compartmental distribution of pyruvate. However, it is well established that the gradient for lactate between the plasma and the erythrocyte is ~2:1 (8). Since Henderson et al. (5) did not measure pyruvate and lactate in the same blood compartment, their comparisons of measured pyruvate and lactate concentrations in venous and arterial samples, leading to their calculated release data, become flawed. Although we did not explicitly state this in our paper (10), both pyruvate and lactate were measured in the same whole blood compartment and via the same methodology. Finally, in the Henderson paper, the assertion of equal pyruvate and lactate release is observed only during the last 15 min of the 60-min exercise bout. When the lactate and pyruvate release is back-calculated at each measured time point over the first 45 min of exercise from their two papers (3, 5), their data seem to be in closer agreement with the existing literature. During the first 45 min of exercise they show a 2.1- to 2.9-fold greater release of lactate than pyruvate. However, they did not report this in their paper.

In conclusion, after further examining the Henderson et al. study (5), we stand by our original conclusions, that "the findings of Henderson et al. (5) seem to be at odds with the majority of published results" and appear to be flawed by several analytical errors. Obviously, with the paucity of existing data, and the current conflicting results and interpretation, we hope that this discussion will encourage more scientific attention and properly conducted and controlled studies examining the metabolic production and release of both pyruvate and lactate from skeletal muscle.

REFERENCES

  1. Ahlborg G, Felig P. Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise. J Clin Invest 69: 45–54, 1982.[ISI][Medline]
  2. Bangsbo J, Gibala MJ, Krustrup P, Gonzalez-Alonso J, Saltin B. Enhanced pyruvate dehydrogenase activity does not affect muscle O2 uptake at onset of intense exercise in humans. Am J Physiol Regul Integr Comp Physiol 282: R273–R280, 2002.[Abstract/Free Full Text]
  3. Bergman BC, Wolfel EE, Butterfield GE, Lopaschuk GD, Casazza GA, Horning MA, Brooks GA. Active muscle and whole body lactate kinetics after endurance training in men. J Appl Physiol 87: 1684–1696, 1999.[Abstract/Free Full Text]
  4. Harrison MH. Effects on thermal stress and exercise on blood volume in humans. Physiol Rev 65: 149–209, 1985.[Abstract/Free Full Text]
  5. Henderson GC, Horning MA, Lehman SL, Wolfel EE, Bergman BC, Brooks GA. Pyruvate shuttling during rest and exercise before and after endurance training in men. J Appl Physiol 97: 317–325, 2004.[Abstract/Free Full Text]
  6. Henderson GC, Horning MA, Wallis GA, Brooks GA. Pyruvate metabolism in working human skeletal muscle. Am J Physiol Endocrinol Metab 292: E366, 2007.[Free Full Text]
  7. Jansson E, Kaijser L. Leg citrate metabolism at rest and during exercise in relation to diet and substrate utilization in man. Acta Physiol Scand 122: 145–153, 1984.[ISI][Medline]
  8. Juel C, Bangsbo J, Graham T, Saltin B. Lactate and potassium fluxes from human skeletal muscle during and after intense, dynamic, knee extensor exercise. Acta Physiol Scand 140: 147–159, 1990.[ISI][Medline]
  9. Lundgren F, Bennegard K, Elander A, Lundholm K, Schersten T, Bylund-Fellenius AC. Substrate exchange in human limb muscle during exercise at reduced blood flow. Am J Physiol Heart Circ Physiol 255: H1156–H1164, 1988.[Abstract/Free Full Text]
  10. Stellingwerff T, Leblanc PJ, Hollidge MG, Heigenhauser GJ, Spriet LL. Hyperoxia decreases muscle glycogenolysis, lactate production, and lactate efflux during steady-state exercise. Am J Physiol Endocrinol Metab 290: E1180–E1190, 2006.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stellingwerff, T.
Right arrow Articles by Spriet, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stellingwerff, T.
Right arrow Articles by Spriet, L. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.